0001181431-12-005291.txt : 20120202
0001181431-12-005291.hdr.sgml : 20120202
20120202163117
ACCESSION NUMBER: 0001181431-12-005291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120201
FILED AS OF DATE: 20120202
DATE AS OF CHANGE: 20120202
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WORTZMAN MARILYN E
CENTRAL INDEX KEY: 0001235962
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51967
FILM NUMBER: 12566295
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Transcept Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001178711
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330960223
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
BUSINESS PHONE: (510) 215-3500
MAIL ADDRESS:
STREET 1: 1003 W. CUTTING BLVD
STREET 2: SUITE 110
CITY: POINT RICHMOND
STATE: CA
ZIP: 94804
FORMER COMPANY:
FORMER CONFORMED NAME: NOVACEA INC
DATE OF NAME CHANGE: 20020724
4
1
rrd332258.xml
WORTZMAN ANNUAL GRANT
X0304
4
2012-02-01
0
0001178711
Transcept Pharmaceuticals Inc
TSPT
0001235962
WORTZMAN MARILYN E
C/O TRANSCEPT PHARMACEUTICALS, INC.
1003 W. CUTTING BLVD, SUITE 110
POINT RICHMOND
CA
94804
0
1
0
0
VP, Finance
Employee Stock Option (right to buy)
8.09
2012-02-01
4
A
0
30000
0
A
2022-02-01
Common Stock
30000
30000
D
The option vests in forty-eight equal monthly installments beginning March 1, 2012.
/s/ Marilyn Wortzman
2012-02-02